-
Product Insights
Clinical Trials: What to Expect in 2026 - A Preview of Trials Planned to Initiate and Estimated to Complete
Clinical Trials: What to Expect in 2026? Planned and completing trials by phase, geography, sponsor type, therapy area, and DCT adoption. Identify pipeline trends and benchmark competitors with GlobalData insights.
-
Sector Analysis
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Crohn’s Disease Drug Market Forecast and Competitive Intelligence Across the 8MM GlobalData’s Crohn’s Disease market report provides detailed analysis of the therapeutics landscape across the eight major markets (8MM), combining market forecasts, pipeline intelligence, competitive assessment, and treatment usage insights through 2032. The report highlights that Crohn’s Disease drug sales across the 8MM are expected to increase from $9.5 billion to $13.8 billion by 2032, reflecting a CAGR of 3.9%. Growth is supported by the approval and launch of eight...
-
Product Insights
Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025" provides an overview of Gastroesophageal (GE) Junction Carcinomas Clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroesophageal (GE) Junction Carcinomas. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025" provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2025" provides an overview of Borderline Personality Disorder (BPD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Borderline Personality Disorder (BPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Phenylketonuria (PKU) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Phenylketonuria (PKU) - Global Clinical Trials Review, 2025" provides an overview of Phenylketonuria (PKU) Clinical trials scenario. This report provides top line data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Epidermolysis Bullosa - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Epidermolysis Bullosa - Global Clinical Trials Review, 2025" provides an overview of Epidermolysis Bullosa Clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Encephalitis - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Encephalitis - Global Clinical Trials Review, 2025" provides an overview of Encephalitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Encephalitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Bronchiectasis - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Bronchiectasis - Global Clinical Trials Review, 2025" provides an overview of Bronchiectasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Gastroenteritis - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Gastroenteritis - Global Clinical Trials Review, 2025" provides an overview of Gastroenteritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroenteritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.